Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04875585
Title Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC (INNWOP1)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medical University Innsbruck

lung non-small cell carcinoma


Lenvatinib + Pembrolizumab

Age Groups: senior | adult
Covered Countries AUT

No variant requirements are available.